Cargando…
Cardiac Metabolic Deregulation Induced by the Tyrosine Kinase Receptor Inhibitor Sunitinib is rescued by Endothelin Receptor Antagonism
The growing field of cardio-oncology addresses the side effects of cancer treatment on the cardiovascular system. Here, we explored the cardiotoxicity of the antiangiogenic therapy, sunitinib, in the mouse heart from a diagnostic and therapeutic perspective. We showed that sunitinib induces an anaer...
Autores principales: | Sourdon, Joevin, Lager, Franck, Viel, Thomas, Balvay, Daniel, Moorhouse, Rebecca, Bennana, Evangeline, Renault, Gilles, Tharaux, Pierre-Louis, Dhaun, Neeraj, Tavitian, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562214/ https://www.ncbi.nlm.nih.gov/pubmed/28824714 http://dx.doi.org/10.7150/thno.19551 |
Ejemplares similares
-
Sunitinib-induced cardiac hypertrophy and the endothelin axis
por: Sourdon, Joevin, et al.
Publicado: (2021) -
A novel role for myeloid endothelin-B receptors in hypertension
por: Czopek, Alicja, et al.
Publicado: (2019) -
Plasma Pro‐Endothelin‐1 Peptide Concentrations Rise in Chronic Kidney Disease and Following Selective Endothelin A Receptor Antagonism
por: Dhaun, Neeraj, et al.
Publicado: (2015) -
Concurrent imaging of vascularization and metabolism in a mouse model of paraganglioma under anti-angiogenic treatment
por: Facchin, Caterina, et al.
Publicado: (2020) -
Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease
por: Farrah, Tariq E., et al.
Publicado: (2019)